Clinical utility of resting-state functional connectivity magnetic resonance imaging for mood and cognitive disorders

• Published in: Journal of Neural Transmission Vol. 124; no. 7; pp. 821 - 839
• Main Authors: Takamura, T., Hanakawa, T.
• Format: Journal Article
• Language: English
• Published: Vienna Springer Vienna 01.07.2017
• Subjects: Brain - diagnostic imaging; Cognition Disorders - diagnostic imaging; High Impact Review in Neuroscience; Humans; Magnetic Resonance Imaging - methods; Medicine; Medicine & Public Health; Mood Disorders - diagnostic imaging; Neuroimaging - methods; Neurology; Neurology or Psychiatry - Review Article; Neurosciences; Psychiatry; Rest; Functional connectivity (FC); Alzheimer’s disease (AD); Bipolar disorder (BD); Major depressive disorder (MDD); Resting-state functional magnetic resonance imaging (rs-fMRI); Dementia
• ISSN: 0300-9564; 1435-1463; 1435-1463
• DOI: 10.1007/s00702-017-1710-2

Although functional magnetic resonance imaging (fMRI) has long been used to assess task-related brain activity in neuropsychiatric disorders, it has not yet become a widely available clinical tool. Resting-state fMRI (rs-fMRI) has been the subject of recent attention in the fields of basic and clinical neuroimaging research. This method enables investigation of the functional organization of the brain and alterations of resting-state networks (RSNs) in patients with neuropsychiatric disorders. Rs-fMRI does not require participants to perform a demanding task, in contrast to task fMRI, which often requires participants to follow complex instructions. Rs-fMRI has a number of advantages over task fMRI for application with neuropsychiatric patients, for example, although applications of task fMR to participants for healthy are easy. However, it is difficult to apply these applications to patients with psychiatric and neurological disorders, because they may have difficulty in performing demanding cognitive task. Here, we review the basic methodology and analysis techniques relevant to clinical studies, and the clinical applications of the technique for examining neuropsychiatric disorders, focusing on mood disorders (major depressive disorder and bipolar disorder) and dementia (Alzheimer’s disease and mild cognitive impairment).